ST. LOUIS (CN) – KV Pharmaceutical and its subsidiaries Ethex and Ther-Rx made drugs that failed to meet FDA standards, a class action claims in Federal Court. The class claims KV recalled several products in January, including Metoprolol Succinate tablets, a hypertension medication.
Named plaintiff Allen Lefaivre says the FDA’s most recent inspection of KV’s facilities found more than 35 problems, including failure to keep equipment clean and failure to follow written process control procedures for production.
Lefaivre claims KV has a history of falling short of FDA standards.
KV received FDA warnings after eight inspections between 2003 and 2009, the suit states. The class includes any U.S. citizen who consumed Metoprolol Succinate tablets made by KV. The class is represented by Robert Blitz.